Short- and Medium-Term Outcomes Assessment of Urethral Prostatic Lift (UroLift) as a Minimally Invasive Treatment for Benign Prostatic Hyperplasia in a Tertiary Care Centre
Although transurethral resection of the prostate (TURP) remains the gold standard surgical treatment for BPH, UroLift offers a less minimally invasive approach with better short-term recovery, preservation of sexual function and low complication profile. The failure rate from UroLift from previous studies falls within the range of 7%-22%, and the figures attained in our centre are comparable to these.
Authors
- Mushtaq Hussain (ORCID: https://orcid.org/0000-0002-9439-0999)
- Sahana Sreenivasan
- Anu Manandhar (ORCID: https://orcid.org/0000-0002-7970-4443)
- Tamara Lezama
- Anthony W. Parker (ORCID: https://orcid.org/0000-0003-1745-399X)
- Anna Akpala
- Kehinde Jinadu
Institutions
- University of Alabama at Birmingham Hospital (US)
- Queen Elizabeth Hospital Birmingham (GB)
- NIHR Surgical Reconstruction and Microbiology Research Centre (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
Publication Details
- Journal
- Cureus
- Published
- 2024-12-12
- DOI
- https://doi.org/10.7759/cureus.75579
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.54